Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The investigation is a single centre, interventional, prospective, non-randomized, open-label, uncontrolled, single arm, un-blinded investigation for evaluation of safety and performance of the medical device M-AOX-2021 in the treatment of wrinkles and imperfections. The clinical investigation is interventional and prospective in agreement with the pre-market regulatory status of the product.
Epistemonikos ID: 9f54b2b2adf369ce4809732b880ab08a005c7737
First added on: Aug 01, 2024